| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CLYM
Climb Bio
|
Jun 12, 2026 | BUY |
Strong Buy
+57.9% avg upside
18 analysts
|
— | · |
|
IRON
Disc Medicine
|
Jun 02, 2026 | BUY |
Strong Buy
+20.2% avg upside
21 analysts
|
— | +3.1% |
|
XFOR
X4 Pharmaceuticals
|
Jun 02, 2026 | BUY |
Strong Buy
+491.4% avg upside
15 analysts
|
$12.00
184.28% Upside
|
+1.0% |
|
EQ
Equillium
|
May 28, 2026 | BUY |
Strong Buy
+181.9% avg upside
14 analysts
|
$6.00
96.63% Upside
|
-2.5% |
|
RNAC
Cartesian Therapeutics
|
May 27, 2026 | BUY |
Strong Buy
+228.2% avg upside
19 analysts
|
— | +28.6% |
|
ALMS
Alumis Inc.
|
May 15, 2026 | BUY |
Strong Buy
+63.6% avg upside
11 analysts
|
$32.00
36.60% Upside
|
+0.8% |
|
SYRE
Spyre Therapeutics
|
Apr 13, 2026 | BUY |
Strong Buy
-15.4% avg upside
23 analysts
|
$106.00
19.92% Upside
|
+32.1% |
|
VRDN
Viridian Therapeutics
|
Apr 06, 2026 | BUY |
Strong Buy
+103.7% avg upside
32 analysts
|
$50.00
200.65% Upside
|
+15.8% |
|
IMVT
Immunovant
|
Apr 02, 2026 | BUY |
Strong Buy
+8.9% avg upside
24 analysts
|
$50.00
41.47% Upside
|
+41.7% |
|
EVMN
Evommune, Inc.
|
Mar 06, 2026 | BUY |
Strong Buy
+134.6% avg upside
12 analysts
|
$52.00
143.47% Upside
|
-24.3% |
|
AGMB
AgomAb Therapeutics NV ADR
|
Mar 03, 2026 | BUY |
Strong Buy
+138.5% avg upside
3 analysts
|
$36.00
227.92% Upside
|
· |
|
CNTB
Connect Biopharma Holdings
|
Jan 13, 2026 | BUY |
Strong Buy
+226.3% avg upside
11 analysts
|
— | +7.3% |
|
IVA
Inventiva
|
Jan 11, 2026 | BUY |
Strong Buy
+350.1% avg upside
16 analysts
|
$12.00
236.10% Upside
|
-33.6% |
|
KYTX
Kyverna Therapeutics, Inc.
|
Dec 15, 2025 | BUY |
Strong Buy
+238.7% avg upside
7 analysts
|
$32.00
296.62% Upside
|
-25.7% |
|
SE:HNSA
Hansa Biopharma AB
|
Nov 26, 2025 | BUY |
Strong Buy
+335.3% avg upside
4 analysts
|
$102.00
216.48% Upside
|
· |
|
VKTX
Viking Therapeutics
|
Oct 23, 2025 | BUY |
Strong Buy
+141.1% avg upside
30 analysts
|
$118.00
288.42% Upside
|
-12.6% |
|
SABS
SAB Biotherapeutics
|
Oct 21, 2025 | BUY |
Strong Buy
+161.3% avg upside
13 analysts
|
— | +23.3% |
|
ACRS
Aclaris Therapeutics
|
Oct 15, 2025 | BUY |
Strong Buy
+122.5% avg upside
15 analysts
|
$7.00
55.65% Upside
|
+123.8% |
|
ABVX
Abivax SA Sponsored ADR
|
Oct 08, 2025 | BUY |
Strong Buy
+20.7% avg upside
15 analysts
|
$115.00
16.03% Upside
|
+15.8% |
|
MLTX
MoonLake Immunotherapeutics
|
Oct 01, 2025 | BUY |
Strong Buy
+51.6% avg upside
20 analysts
|
$14.00
27.09% Downside
|
+171.8% |
|
ARGX
Argenx Se
|
Sep 17, 2025 | BUY |
Strong Buy
-15.9% avg upside
46 analysts
|
$780.00
11.22% Downside
|
+20.2% |
|
MDGL
Madrigal Pharmaceuticals
|
Aug 19, 2025 | BUY |
Strong Buy
-5.8% avg upside
31 analysts
|
— | +26.7% |
|
CLDX
Celldex
|
Aug 19, 2025 | BUY |
Strong Buy
+20.6% avg upside
28 analysts
|
— | +34.7% |
|
SGMT
Sagimet Biosciences, Inc. Class A
|
Aug 18, 2025 | BUY |
Strong Buy
+317.2% avg upside
15 analysts
|
$26.00
289.30% Upside
|
-8.6% |
|
ELDN
Eledon Pharmaceuticals
|
Aug 15, 2025 | BUY |
Strong Buy
+302.0% avg upside
10 analysts
|
$8.00
104.09% Upside
|
+44.5% |
|
KROS
Keros Therapeutics
|
Aug 07, 2025 | BUY |
Strong Buy
+139.0% avg upside
21 analysts
|
$35.00
228.67% Upside
|
-21.4% |
|
QTTB
Q32 Bio
|
Apr 16, 2025 | HOLD |
Buy
+345.2% avg upside
24 analysts
|
— | +209.2% |
|
PRTCY
PureTech Health
|
Aug 28, 2024 | BUY |
Strong Buy
+194.2% avg upside
3 analysts
|
$58.00
234.55% Upside
|
· |
|
TRVI
Trevi Therapeutics
|
Aug 08, 2024 | BUY |
Strong Buy
+17.4% avg upside
16 analysts
|
$6.00
65.10% Downside
|
+165.0% |
|
IMUX
Immunic
|
Aug 08, 2024 | HOLD |
Strong Buy
+166.0% avg upside
21 analysts
|
$5.00
64.74% Downside
|
-34.9% |
|
MNKD
MannKind
|
Aug 07, 2024 | BUY |
Buy
+78.6% avg upside
22 analysts
|
$7.00
77.74% Upside
|
-31.5% |
|
KYMR
Kymera Therapeutics
|
Aug 07, 2024 | HOLD |
Strong Buy
+8.9% avg upside
36 analysts
|
$33.00
63.45% Downside
|
+1.3% |
|
PLRX
Pliant Therapeutics
|
Aug 07, 2024 | BUY |
Buy
+1821.1% avg upside
21 analysts
|
$46.00
3865.42% Upside
|
-86.6% |
|
SVRN
OceanPal Inc
|
Mar 15, 2024 | BUY |
Strong Buy
6 analysts
|
— | · |
|
DMRA
Damora Therapeutics
|
Aug 15, 2023 | HOLD |
Strong Buy
+28.3% avg upside
19 analysts
|
$2.00
90.52% Downside
|
· |
|
GB:PRTC
PureTech Health
|
Aug 08, 2022 | BUY |
Strong Buy
+3934.4% avg upside
1 analyst
|
$5301.22
3934.42% Upside
|
· |
|
PBYI
Puma Biotechnology
|
Jan 17, 2019 | HOLD |
Buy
+458.2% avg upside
11 analysts
|
$21.00
177.79% Upside
|
-61.8% |
|
TXMD
TherapeuticsMD
|
Sep 08, 2017 | HOLD |
Buy
+220.5% avg upside
8 analysts
|
$6.00
207.69% Upside
|
-7.0% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.